LENZ Therapeutics (LENZ) EPS (Basic) (2020 - 2026)
LENZ Therapeutics' (LENZ) quarterly EPS (Basic) came in at -$1.35 in Q1 2026, down 132.95% year-on-year from $4.09 in Q1 2025, and down 8.06% on a QoQ basis from -$1.25 in Q4 2025.
LENZ Therapeutics (LENZ) EPS (Basic) (2020 - 2026) Analysis & Trends
LENZ Therapeutics (LENZ) has 7 years of EPS (Basic) data on file, last reported at -$1.35 in Q1 2026.
- On a quarterly basis, EPS (Basic) fell 132.95% year-over-year to -$1.35 in Q1 2026; TTM through Mar 2026 was -$3.5, a 96.47% decrease from a year earlier, with the FY2025 full-year figure at -$2.85, down 21.88% from the prior year.
- EPS (Basic) for Q1 2026 stood at -$1.35, down from -$1.25 in the prior quarter.
- Over the last five years, EPS (Basic) for LENZ reached as high as -$0.38 in Q3 2024 and fell as low as -$81.63 in Q2 2022.
- Historically, EPS (Basic) has averaged -$7.02 across 5 years, with a median of -$2.18 in 2023.
- Across the five-year window, EPS (Basic) jumped 94.22% in 2024 and plunged 132.95% in 2026, its largest moves.
- Year by year, EPS (Basic) stood at -$3.62 in 2022, then jumped by 38.28% to -$2.23 in 2023, then surged by 73.36% to -$0.59 in 2024, then plunged by 109.55% to -$1.25 in 2025, then retreated by 8.06% to -$1.35 in 2026.
- Per Business Quant data, the three most recent EPS (Basic) figures were -$1.35 in Q1 2026, -$1.25 in Q4 2025, and -$0.59 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.16 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 0.00 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 0.00 |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 7.59 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -2.29 |
| 10 | LENZ Therapeutics | 158.34 Mn | 158.34 Mn | 825,000.00 | -1.35 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.35 |
| Dec 31, 2025 | -1.25 |
| Sep 30, 2025 | -0.59 |
| Jun 30, 2025 | -0.53 |
| Mar 31, 2025 | -0.58 |
| Dec 31, 2024 | -0.59 |
| Sep 30, 2024 | -0.38 |
| Jun 30, 2024 | -0.40 |
| Mar 31, 2024 | -3.42 |
| Dec 31, 2023 | -2.23 |
| Sep 30, 2023 | -6.51 |
| Jun 30, 2023 | -6.14 |
| Mar 31, 2023 | -2.18 |
| Dec 31, 2022 | -3.62 |
| Sep 30, 2022 | -4.34 |
| Jun 30, 2022 | -81.63 |
| Mar 31, 2022 | -3.58 |
| Dec 31, 2021 | -5.07 |
| Sep 30, 2021 | -7.29 |
| Jun 30, 2021 | -179.61 |